Characteristics at baseline | Â |
---|---|
Age (years) (μ, SD) | 58.8 ± 8.0 |
Men, n (%) | 892 (85.0%) |
CYP2C19C*2 allele frequency | Â |
   - AA | 27 (2.6%) |
   - AG | 279 (26.6%) |
   - GG | 744 (70.9%) |
History of myocardial infarction, n (%) | 611 (58.2%) |
History of heart failure, n (%) | 128 (12.6%) |
Clinical score (angiographic evaluation) | Â |
   - 1 vessel disease | 255 (24.3%) |
   - 2 vessel disease | 279 (26.6%) |
   - 3 vessel disease | 449 (42.8%) |
   - unknown | 52 (5.0%) |
School education <10 yrs., n (%) | 625 (59.5%) |
Body mass index (kg/m2), (μ, SD) | 27.1 ± 3.5 |
History of diabetes, n (%) | 184 (17.7%) |
Total cholesterol (mg/dl) (μ, SD) | 168.9 (32.6) |
LDL-cholesterol (mg/dl) (μ, SD) | 100.4 (28.9) |
HDL-cholesterol (mg/dl) (μ, SD) | 39.4 (10.5) |
C-reactive protein (mg/L) * | 3.47 (1.23; 8.37) |
Creatinine Clearance (mL/min) * | 93.75 (78.20; 115.00) |
Cystatin C (mg/L)* | 1.03 (0.93; 1.19) |
NT-proBNP (pg/mL)* | 572.00 (279.90; 1101.00) |
GRACE Score (points) (μ, SD) | 95.9 (20.8) |